Tove Wästerlid

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Cancer Research Cancer Research professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (10)

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2021

Year:

2020

Collaborators (10)

Tarec Christoffer El‐Galaly

DENMARK

View details

Lotta Hansson

Karolinska Institutet

SWEDEN

View details

Sara Harrysson

Karolinska University Hospital

SWEDEN

View details

Tom Mulder

Karolinska Institutet

SWEDEN

View details

Joel Joelsson

Karolinska Institutet

SWEDEN

View details

Cecilia Radkiewicz

Karolinska Institutet

SWEDEN

View details

Richard Rosenquist

Karolinska Institutet

SWEDEN

View details

Elisavet Syriopoulou

Karolinska Institutet

SWEDEN

View details

Henrik Frederiksen

DENMARK

View details

Marzia Palma

Karolinska University Hospital

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Tove Wästerlid

Research Interests

Explore related searches

Contact this professor

Articles (10)

Sex differences in lymphoma incidence and mortality by subtype: A population‐based study

Standardised survival probabilities: a useful and informative tool for reporting regression models for survival data

Incidence and time trends of second primary malignancies after non-Hodgkin lymphoma: a Swedish population-based study

Application of precision medicine in clinical routine in haematology-Challenges and opportunities.

Excellent survival after R‐Hyper‐CVAD in hospitalized patients with high‐risk large B‐cell lymphoma: The Karolinska experience

Real-world data on treatment and outcomes of patients with primary mediastinal large B-cell lymphoma: a Swedish lymphoma register study

Statin use and survival in 16 098 patients with non‐Hodgkin lymphoma or chronic lymphocytic leukaemia treated in the rituximab era

Temporary cessation of ibrutinib results in reduced grade 3‐4 infections and durable remissions—Interim analysis of an on‐off‐repeat Phase 1b/2 study in patients with chronic lymphocytic leukemia

Clinical characteristics and outcomes among 2347 patients aged ≥85 years with major lymphoma subtypes: a Nordic Lymphoma Group study

Outcome and determinants of failure to complete primary R‐CHOP treatment for reasons other than non‐response among patients with diffuse large B‐cell lymphoma

Collaborators (10)

Tarec Christoffer El‐Galaly

Lotta Hansson

Sara Harrysson

Tom Mulder

Joel Joelsson

Cecilia Radkiewicz

Richard Rosenquist

Elisavet Syriopoulou

Henrik Frederiksen

Marzia Palma

Make your next move.